Jaguar Health Files 8-K: Material Agreement & Financials

Ticker: JAGX · Form: 8-K · Filed: May 5, 2025 · CIK: 1585608

Sentiment: neutral

Topics: material-agreement, financials, corporate-action

TL;DR

Jaguar Health filed an 8-K on 5/5/25 for a material agreement and financials.

AI Summary

On May 5, 2025, Jaguar Health, Inc. filed an 8-K report detailing a material definitive agreement and financial statements. The company, formerly known as Jaguar Animal Health, Inc., is incorporated in Delaware and headquartered in San Francisco, California.

Why It Matters

This filing indicates significant corporate actions and financial reporting by Jaguar Health, Inc., which could impact investors and stakeholders.

Risk Assessment

Risk Level: low — This is a routine filing reporting a material agreement and financial statements, not indicating immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement filed by Jaguar Health, Inc. on May 5, 2025?

The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in this excerpt.

What financial statements are included in this 8-K filing?

The filing lists 'Financial Statements and Exhibits' as an item of disclosure, but the specific financial statements are not detailed in this excerpt.

When was Jaguar Health, Inc. formerly known as Jaguar Animal Health, Inc.?

The company changed its name from Jaguar Animal Health, Inc. on August 30, 2013.

Where are Jaguar Health, Inc.'s principal executive offices located?

The principal executive offices are located at 200 Pine Street Suite 400, San Francisco, California, 94104.

What is the SIC code for Jaguar Health, Inc.?

The Standard Industrial Classification code for Jaguar Health, Inc. is 2834, Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding Jaguar Health, Inc. (JAGX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing